Abstract:T he study by Guo et al examines the in vitro protective effect of culture supernatants from 2 probiotic bacteria, Bifidobacterium infantis and Lactobacillus acidophilus, on intestinal epithelial barrier function. Using an epithelial colorectal adenocarcinoma cell line (Caco-2) assay, the authors demonstrate that preincubation with sterile, cell-free culture supernatants (CFS) from either of these 2 bacterial strains prevented interleukin-1b-induced intestinal barrier permeability as measured by transepithelial electrical resistance and fluorescein isothiocyanate-labeled dextran flux. Protection was mediated by preventing both interleukin-1b-induced increases in tight junction protein claudin-1 expression and nuclear factor-kB activation. These observations add to a growing body of evidence that probiotic bacteria and, more specifically, their cell-associated and secreted products promote integrity of epithelial barrier function and maintenance of intestinal homeostasis (1–4). pH is a key determinant of bioactivity; L acidophilus and B infantis used in this study produce lactate that acidifies the conditioned culture medium and likely influences the bioactivity of associated microbial-derived products. In the described study, the authors adjust the cell-free supernatant to pH 7.4. Luminal pH in the healthy lower gastrointestinal tract is, however, site-specific and ranges from 5.5 to 7.5 (though patients with gastrointestinal disease frequently exhibit deviations from these mean values (5)). This raises the possibility that the bioactivity of the CFS in vitro may be distinct from in vivo conditions in the gastrointestinal tract and supports screening the bioactivity of these conditioned culture media across the range of pH conditions found in the lower gut. Questions also naturally arise as to whether this beneficial effect of probiotic strain-derived CFS is exclusive to these probiotic species, or if CFS from other bacteria, including those typically considered pathogenic, may also derive a similar effect under the epithelial culture conditions examined. Although it is critical to understand the efficacy of single species and the mechanisms by which they promote barrier function, the complex microbial communities found in the gastrointestinal tract (human microbiome), even in the earliest phases of life, may influence bioavailability of consumed or orally administered bioactives. Microbial members within the human gastrointestinal microbiome compete with each other and the host for resources. To date, the microbial-derived products that promote barrier function include short-chain fatty acids such as acetate produced by Bifidobacteria, which prevent epithelial barrier disruption through tumor necrosis factor-a induction (1). Such products, however, represent attractive carbon sources for a broad range of gastrointestinal organisms (6–8). Hence, whether oral supplementation with probiotic-derived products would lead to effective epithelial bioavailbility in the distal gastrointestinal tract in humans remains to be determined. Ideally, a single microbial-derived product within the conditioned media of these species promotes epithelial integrity. There are, however, multiple candidate mechanisms and likely as many microbial-derived and associated products that may promote barrier function. These may include pH modification via production of lactic acid or other short-chain fatty acids (7), lipid-derived induction of anti-inflammatory innate and adaptive immune responses (9), and/or triggering of toll-like receptor signaling pathways (4,10), which may act synergistically to promote epithelial integrity. Moreover, the gastrointestinal tract is overtly colonized from early life, so while promoting barrier function may reduce proinflammatory responses it is unlikely to correct associated gut microbial dysbioses. As such, the efficacy of such a therapeutic strategy may be enhanced by preconditioning the gastrointestinal tract with microbial-derived products to promote barrier integrity and reduce proinflammatory responses, followed by oral supplementation with a relatively simple and defined inoculum of microbial species to promote appropriate microbiome (re)development. Probiotics have gained enormous interest in recent years as a means to promote intestinal homeostasis; however, much more work is needed to fully elucidate their mechanism(s) of action. The observations reported in this study are important because they provide initial evidence for promotion of barrier function via probiotic-derived products. Understanding the mechanism(s) by which microbes and their products beneficially alter host physiology holds much promise for a broad range of conditions, not least as a precursor treatment for highly vulnerable populations such as premature neonates at high risk of necrotizing enterocoilitis.

Regulation of intestinal peptidases by nutrients in human fetuses and children

Intestinal Fatty Acid Binding Protein and Dipeptide Transporter 1 Mrna in the Small Intestinal Mucosa of Weaner Piglets: Developmental Expression and Influence of Glutamine.

Inhibitors of Mitogen Activated Protein Kinase Pathways: Effects on Intestinal Morphology and Permeability of Weaner Piglets

Effect of polyunsaturated fatty acids on postnatal ileum development using the fat-1 transgenic mouse model

Exposure to plant-oriented microbiome altered jejunal and colonic innate immune response and barrier function more strongly in suckling than in weaned piglets

The effect of dietary supplementation of low crude protein on intestinal morphology in pigs

Regulation of peptide-YY synthesis and secretion in fetal rat intestinal cultures

Properties and Regulation of Gly-Sar Uptake and Transport in Bovine Intestinal Epithelial Cells.

Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients

Dose-related effects of early-life intake of sn-2 palmitate, a specific positionally distributed human milk fatty acid, on the composition and metabolism of the intestinal microbiota

Expression and regulation of the neutral amino acid transporter B0AT1 in rat small intestine

PERINATAL CHANGES IN THE ACTIVATION AND ESTERIFICATION OF FATTY ACIDS IN THE RAT INTESTINAL MUCOSA

PSI-28 Genomic Determinants of Alkaline Phosphatase Catalytic Affinity along the Intestinal Longitudinal Axis of Weanling Pigs.

Catabolism of Nutritionally Essential Amino Acids in Developing Porcine Enterocytes.

Nutritional Factors Influencing Intestinal Health of the Neonate

Pre- and postnatal protein undernutrition increases hepatic carnitine palmitoyltransferase I activity and decreases enzyme sensitivity to inhibitors in the suckling rat

Amino Acid Deprivation Disrupts Barrier Function and Induces Protective Autophagy in Intestinal Porcine Epithelial Cells

The effect of prebiotics on intestinal barrier function in rats with acute pancreatitis

Regulatory Role of Phosphoproteins in the Development of Bovine Small Intestine During Early Life.

Intestinal Alkaline Phosphatase Promotes Gut Bacterial Growth by Reducing the Concentration of Luminal Nucleotide Triphosphates.

Promotion of Epithelial Barrier Integrity Via Probiotic-derived Products.